Morbidity and Mortality in Patients Coinfected with Human Immunodeficiency Virus and Hepatitis B Virus
Innovative Insights in Case Reports and Reviews · 03.11.2025
DOI: 10.67335/3070-5681.1009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innovative Insights in Case Reports and Reviews, online erschienen am 03.11.2025. Verfasst von José Pedro Lutaevono.
Abstract (Originalsprache)
Introduction
Coinfection with Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV) is a global public health problem, particularly in high-endemicity regions like sub-Saharan Africa. This coinfection is associated with an accelerated progression of liver disease and a worse prognosis.
Objective
To evaluate morbidity and mortality in patients treated at Hospital Américo Boavida in Angola with HIV/HBV coinfection (2010-2012).
Methods
A retrospective descriptive study was conducted in the Infectious and Parasitic Diseases Service (SDIP) of Hospital Américo Boavida between 2010 and 2012. Out of a total of 2397 hospitalized patients, 237 (9.9 %) with confirmed positive serology for both viruses constituted the sample. Sociodemographic, clinical, laboratory, and treatment data were collected from medical records.
Results
The coinfection prevalence was 9.9 %. The median age was 26-35 years (38 %), with a predominance of females (62 %). The most common risk factor was heterosexuality (40.1 %). Most patients presented with WHO clinical stage IV (42.2 %) with CD4 counts
Zitieren
APA
Lutaevono, J. P. (2025). Morbidity and Mortality in Patients Coinfected with Human Immunodeficiency Virus and Hepatitis B Virus. Innovative Insights in Case Reports and Reviews. https://doi.org/10.67335/3070-5681.1009
Vancouver
Lutaevono JP. Morbidity and Mortality in Patients Coinfected with Human Immunodeficiency Virus and Hepatitis B Virus. Innovative Insights in Case Reports and Reviews. 2025. doi:10.67335/3070-5681.1009
BibTeX
@article{Lutaevono2025,
author = {Lutaevono, José Pedro},
title = {Morbidity and Mortality in Patients Coinfected with Human Immunodeficiency Virus and Hepatitis B Virus},
journal = {Innovative Insights in Case Reports and Reviews},
year = {2025},
doi = {10.67335/3070-5681.1009}
}
EUVIMED